Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Yuanlong Ge; Shu Wu; Zepeng Zhang; Xiaocui Li; Feng Li; Siyu Yan; Haiying Liu; Junjiu Huang; Yong Zhao

doi:10.1007/s13238-019-0640-1

Protein Cell ›› 2019, Vol. 10 ›› Issue (12) :927 -928. DOI: 10.1007/s13238-019-0640-1

Correction

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Author information +

History +

PDF (2442KB)

Graphical abstract

Cite this article

Download citation ▾

Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao. Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers. Protein Cell, 2019, 10 (12) : 927-928 DOI:10.1007/s13238-019-0640-1

登录浏览全文

4963

注册一个新账户忘记密码

CORRECTION TO: PROTEIN CELL HTTPS://DOI.ORG/10.1007/S13238-019-0634-Z

In the original publication the labels in Fig. 4C and 4D are incorrectly published. The correct labels for Fig. 4C and 4D is provided in this correction.

The original article can be found online at https://doi.org/10.1007/s13238-019-0634-z.